Description

Bortezomib Injection 3.5mg is a proteasome inhibitor used in the treatment of multiple myeloma and certain lymphomas. By disrupting protein degradation in cancer cells, it promotes apoptosis, inhibits tumor growth, and significantly improves overall survival rates for affected patients.